Literature DB >> 35804248

Current status of the association between malnutrition defined by the GLIM criteria and postoperative outcomes in gastrointestinal surgery for cancer: a narrative review.

Ryota Matsui1,2, Kazuma Rifu3, Jun Watanabe3,4, Noriyuki Inaki5, Tetsu Fukunaga6.   

Abstract

In 2018, the Global Leadership Initiative on Malnutrition consortium published global consensus diagnostic criteria for malnutrition and highlighted the association between malnutrition and poor postoperative outcomes in patients with gastrointestinal cancer. The aforementioned criteria consist of phenotypic and etiologic criteria to diagnose malnutrition in individuals who undergo conventional screening to determine the at-risk population. Recent studies have reported the usefulness of prediction of postoperative outcomes using body mass index, weight loss, and reduced muscle mass as phenotypic criteria. Reduced muscle mass is an essential diagnostic criterion for sarcopenia, which is associated with poor outcomes in patients with cancer. The Global Leadership Initiative on Malnutrition criteria define reduced muscle mass as undernutrition. Malnutrition diagnosed based on the Global Leadership Initiative on Malnutrition criteria is an important risk factor for postoperative complications and also an independent poor prognostic factor for long-term outcomes; greater severity of malnutrition is associated with poorer outcomes. The current Global Leadership Initiative on Malnutrition criteria for malnutrition accurately predict outcomes, including postoperative complications and long-term prognosis; however, a revision may be warranted to ensure consistency with the diagnostic criteria for sarcopenia. Patients diagnosed with malnutrition based on the Global Leadership Initiative on Malnutrition criteria should be targeted for nutritional intervention. Further accumulation of evidence is necessary to conclusively establish the role of nutritional interventions in patients with malnutrition to improve postoperative complications and long-term outcomes.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  GLIM criteria; Gastrointestinal surgery; Malnutrition; Nutritional screening; Postoperative complications; Prognosis

Year:  2022        PMID: 35804248     DOI: 10.1007/s00432-022-04175-y

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  39 in total

1.  Gait speed predicts post-operative medical complications in elderly gastric cancer patients undergoing gastrectomy.

Authors:  Arvine Chandoo; Chu-Huai Chi; Weiping Ji; Yingpeng Huang; Xiao-Dong Chen; Wei-Teng Zhang; Rui-Sen Wu; Xian Shen
Journal:  ANZ J Surg       Date:  2017-12-11       Impact factor: 1.872

2.  Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study.

Authors:  Dong-Dong Huang; Xiao-Xi Chen; Xi-Yi Chen; Su-Lin Wang; Xian Shen; Xiao-Lei Chen; Zhen Yu; Cheng-Le Zhuang
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-29       Impact factor: 4.553

3.  Prevalence of Malnutrition Among Gastric Cancer Patients Undergoing Gastrectomy and Optimal Preoperative Nutritional Support for Preventing Surgical Site Infections.

Authors:  Yasunari Fukuda; Kazuyoshi Yamamoto; Motohiro Hirao; Kazuhiro Nishikawa; Sakae Maeda; Naotsugu Haraguchi; Masakazu Miyake; Naoki Hama; Atsushi Miyamoto; Masataka Ikeda; Shoji Nakamori; Mitsugu Sekimoto; Kazumasa Fujitani; Toshimasa Tsujinaka
Journal:  Ann Surg Oncol       Date:  2015-08-19       Impact factor: 5.344

4.  The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review.

Authors:  Ross D Dolan; Barry J A Laird; Paul G Horgan; Donald C McMillan
Journal:  Crit Rev Oncol Hematol       Date:  2018-10-05       Impact factor: 6.312

Review 5.  A systematic review of the effect of preoperative nutrition support on nutritional status and treatment outcomes in upper gastrointestinal cancer resection.

Authors:  Irene Deftereos; Nicole Kiss; Elizabeth Isenring; Vanessa M Carter; Justin Mc Yeung
Journal:  Eur J Surg Oncol       Date:  2020-04-18       Impact factor: 4.424

6.  GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.

Authors:  T Cederholm; G L Jensen; M I T D Correia; M C Gonzalez; R Fukushima; T Higashiguchi; G Baptista; R Barazzoni; R Blaauw; A Coats; A Crivelli; D C Evans; L Gramlich; V Fuchs-Tarlovsky; H Keller; L Llido; A Malone; K M Mogensen; J E Morley; M Muscaritoli; I Nyulasi; M Pirlich; V Pisprasert; M A E de van der Schueren; S Siltharm; P Singer; K Tappenden; N Velasco; D Waitzberg; P Yamwong; J Yu; A Van Gossum; C Compher
Journal:  Clin Nutr       Date:  2018-09-03       Impact factor: 7.324

7.  Value of muscle quality, strength and gait speed in supporting the predictive power of GLIM-defined malnutrition for postoperative outcomes in overweight patients with gastric cancer.

Authors:  Dong-Dong Huang; Gao-Feng Wu; Xin Luo; Hao-Nan Song; Wen-Bin Wang; Na-Xin Liu; Zhen Yu; Qian-Tong Dong; Xiao-Lei Chen; Jing-Yi Yan
Journal:  Clin Nutr       Date:  2021-02-03       Impact factor: 7.324

8.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

9.  GLIM vs ESPEN criteria for the diagnosis of early malnutrition in oncological outpatients.

Authors:  Marta Gascón-Ruiz; Diego Casas-Deza; Irene Torres-Ramón; María Zapata-García; Natalia Alonso; Andrea Sesma; Julio Lambea; María Álvarez-Alejandro; Elisa Quílez; Dolores Isla; Jose M Arbonés-Mainar
Journal:  Clin Nutr       Date:  2021-04-22       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.